Stonepine Capital Management, LLC 13D and 13G filings for Adamas Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 7:47 pm Sale | 2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | Stonepine Capital Management, LLC | 0 0.000% | -3,408,849 (Position Closed) | Filing |
| 2021-03-01 6:06 pm Purchase | 2021-02-25 | 13G | Adamas Pharmaceuticals, Inc. ADMS | Stonepine Capital Management, LLC | 3,408,849 7.600% | 2,600,418 (+321.66%) | Filing |
| 2021-02-12 4:48 pm Sale | 2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | Stonepine Capital Management, LLC | 808,431 2.800% | -1,432,808 (-63.93%) | Filing |